Embracing serialisation by driving adoption beyond compliance mandates
As countries explore serialisation mandates, Johnson & Johnson leverages its robust GS1-based program to protect vulnerable markets and products globally...
Body
Despite serialisation being mandated in approximately 52 countries, many of the countries most at risk remain unregulated. In the absence of regulation, pharmaceuticals may be more vulnerable to product counterfeiting, diversion or adulteration.
File
